Analyst Price Targets — PATH
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| June 1, 2026 1:22 pm | — | New Street | $13.00 | $12.82 | TheFly | UiPath price target lowered to $13 from $14 at BMO Capital |
| May 29, 2026 1:12 pm | Lucky Schreiner | D.A. Davidson | $12.00 | $11.60 | StreetInsider | UiPath Inc. (PATH) PT Lowered to $12 at DA Davidson as Growth 'Adequately Priced in' |
| March 12, 2026 11:10 am | Scott Berg | Needham | $15.00 | $12.38 | StreetInsider | Needham Upgrades UiPath Inc. (PATH) to Buy 'on NN ARR Growth, FCF Growth' |
| March 12, 2026 9:57 am | Radi Sultan | UBS | $13.00 | $12.38 | StreetInsider | UiPath Inc. (PATH) PT Lowered to $13 at UBS |
| February 11, 2026 12:30 pm | — | RBC Capital | $14.00 | $12.95 | TheFly | UiPath price target lowered to $14 from $17 at RBC Capital |
| January 12, 2026 11:22 am | — | Barclays | $18.00 | $16.32 | TheFly | UiPath price target raised to $18 from $16 at Barclays |
| January 5, 2026 11:26 am | — | RBC Capital | $17.00 | $15.88 | TheFly | UiPath price target lowered to $17 from $19 at RBC Capital |
| December 10, 2025 1:19 pm | Matthew Hedberg | RBC Capital | $19.00 | $18.40 | StreetInsider | UiPath Inc. (PATH) PT Raised to $19 at RBC Capital |
| December 9, 2025 1:11 pm | Sanjit Singh | Morgan Stanley | $19.00 | $19.35 | TheFly | UiPath price target raised to $19 from $15 at Morgan Stanley |
| December 4, 2025 6:37 pm | — | Truist Financial | $17.00 | $18.45 | TheFly | UiPath price target raised to $17 from $12 at Truist |
Latest News for PATH
Zacks.com users have recently been watching UiPath (PATH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
UiPath delivers automation software and AI-driven solutions to streamline enterprise workflows across major global industries.
PATH tops Q1 FY27 estimates as AI-driven automation demand boosts ARR growth, enterprise expansion deals and profitability gains.
UiPath, Inc. (PATH) Q1 2027 Earnings Call Transcript
UiPath NYSE: PATH reported a stronger-than-expected start to fiscal 2027, with management highlighting growth in annual recurring revenue, revenue and profitability, as well as increasing customer adoption of its artificial intelligence and process orchestration products.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for PATH.
U.S. House Trading
No House trades found for PATH.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.